Sequenced Somatic Cell Reprogramming and Differentiation Inside Nested Hydrogel Droplets

Adv Biosyst. 2020 Aug;4(8):e2000071. doi: 10.1002/adbi.202000071. Epub 2020 Jun 28.

Abstract

The efficient genesis of pluripotent cells or therapeutic cells for regenerative medicine involves several external manipulations and conditioning protocols, which drives down clinical applicability. Automated programming of the genesis by microscale physical forces and chronological biochemistry can increase clinical success. The design and fabrication of nested polysaccharide droplets (millimeter-sized) with cell sustaining properties of natural tissues and intrinsic properties for time and space evolution of cell transformation signals between somatic cells, pluripotent cells and differentiated therapeutic cells in a swift and efficient manner without the need for laborious external manipulation are reported. Cells transform between phenotypic states by having single and double nested droplets constituted with extracellular matrix proteins and reprogramming, and differentiation factors infused chronologically across the droplet space. The cell transformation into germ layer cells and bone cells is successfully tested in vitro and in vivo and promotes the formation of new bone tissues. Thus, nested droplets with BMP-2 loaded guests synthesize mineralized bone tissue plates along the length of a cranial non-union bone defect at 4 weeks. The advantages of sequenced somatic cell reprogramming and differentiation inside an individual hydrogel module without external manipulation, promoted by formulating tissue mimetic physical, mechanical, and chemical microenvironments are shown.

Keywords: biomimetic; cell differentiation; cell reprogramming; hydrogels; iPSCs; tissue regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / pharmacology
  • Biomarkers / metabolism
  • Bone Morphogenetic Protein 2 / genetics*
  • Bone Morphogenetic Protein 2 / metabolism
  • Cell Differentiation / drug effects
  • Cell Line
  • Cell- and Tissue-Based Therapy / methods
  • Cellular Reprogramming / drug effects*
  • Cellular Reprogramming / genetics
  • Fibroblast Growth Factors / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Gene Expression
  • Germ Cells / cytology
  • Germ Cells / drug effects
  • Germ Cells / metabolism
  • Humans
  • Hybrid Cells / cytology
  • Hybrid Cells / drug effects
  • Hybrid Cells / metabolism
  • Hydrogels / chemistry
  • Hydrogels / pharmacology*
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / drug effects*
  • Pluripotent Stem Cells / metabolism
  • Polysaccharides / pharmacology*
  • Tissue Engineering / methods
  • Tretinoin / pharmacology
  • Wnt3 Protein / pharmacology

Substances

  • BMP2 protein, human
  • Biomarkers
  • Bone Morphogenetic Protein 2
  • Hydrogels
  • Polysaccharides
  • WNT3 protein, human
  • Wnt3 Protein
  • activin A
  • Activins
  • Tretinoin
  • Fibroblast Growth Factors